Director, Global Medical Excellence
Revolution Medicines - Basel, Basel-Stadt, Switzerland
Posted May 7, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Jun 7, 2026
- Salary
- Not verified
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $93,011 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +5.1% - Faster than average
Matched to SOC 13-1161 - Marketing aggregate by role bucket.
Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Director, Global Medical Excellence Basel, Basel-Stadt, Switzerland Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Director, Global Medical Excellence, supporting the European region to serve as a key scientific and strategic partner to the Head of Global Medical Excellence. This role will help integrate and advance Medical Excellence initiatives across the portfolio for the European region by connecting science, strategy, and execution across the European regional Medical Affairs teams, in collaboration with the global teams. Key Responsibilities - Serve as a scientific thought partner to the Head of Global Medical Excellence, helping translate medical strategy into aligned Medical Excellence priorities. - Connect and integrate scientific themes, data narratives, and strategic objectives across Medical Excellence functions (e.g., publications, content & training, stakeholder engagement, analytics). - Support consistency and quality of scientific messaging and execution across global and regional Medical Affairs activities. Global-Regional Medical Partnership - Act as a key liaison between Global Medical Excellence and regional/local
Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.
Apply link not verified; last-live date unavailable.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
-
Sr Program Director
Honeywell - Switzerland
-
Regional Sales Manager - Symantec Switzerland
Arrow Financial CORP - CH-Wallisellen, Switzerland (Richtistr)